Clinical Trials Browser

Natalizumab × Clear all

NCT06705608 2024-11-26

MS; FTY720

Carcinoma, Basal Cell, Melanoma, Multiple Sclerosis, Skin Neoplasms, Multiple Sclerosis, Relapsing-Remitting

NCT01416181 2017-09-11

ASCEND in SPMS

Phase 3 Terminated

889 enrolled 31 charts

Multiple Sclerosis, Neoplasm Metastasis, Multiple Sclerosis, Chronic Progressive

NCT00675428 2014-09-19

Study of Natalizumab in Relapsed/Refractory Multiple Myeloma

Phase 1/2 Terminated

6 enrolled 6 charts

Multiple Myeloma, Recurrence